Enriching Life Through InnO2vation


Enriching Life Through InnO2vation

Product Portfolio

The first in Belluscura’s product portfolio is the X-PLO2R®, the world’s first modular portable oxygen concentrator. Weighing less than 3.25 lbs. (1.5kg), the lightweight X-PLO2R is designed to enable patients to improve their mobility and stay active.

About Belluscura

We are focused on developing and commercialising innovative oxygen enrichment technologies that span broad industries and therapies.

Our products are designed to create improved health and economic outcomes for patients, healthcare providers and insurance organisations.

Investor Inquiry

Belluscura is a publicly traded UK company listed on the AIM submarket of the London Stock Exchange (AIM: BELL). For information regarding investment opportunities, visit the investor’s page to contact us today.

Enriching Life Through InnO2vation

The air that we breathe is a mixture of various gases, approximately 78% nitrogen, 21% oxygen and 1% other gases such as carbon dioxide, neon, and hydrogen.  Belluscura, working closely with its research partners, develops proprietary oxygen enrichment technology that concentrates ordinary air into enriched oxygen gas. Our patented technology allows us to deliver up to 96% pure oxygen, depending on the clinical need.

Medical Oxygen

Medical Oxygen is used to increase and restore oxygen levels in our bodily tissues. The oxygen is delivered through a variety of methods, to support a wide range of conditions such as COPD, cyanosis, shock, severe hemorrhage, carbon monoxide poisoning, major trauma, and cardiac/respiratory arrest.

Belluscura News

Belluscura Logo

Trending Topics

pulmonary rehabilitation